University research records
Soongsil University
8 imported, source-linked research records. Open-access records.
Open-access records
Back to university profile →8 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to Soongsil University are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–8 of 8 matching records. Counts update as records arrive.
Effects of RAS and SGLT2 inhibitors alone or in combination on end-stage kidney disease and/or all-cause death in patients with both diabetes and hypertension: a nationwide cohort study
July 14, 2025 · 8 citations · Open access
Open original record →Holistic and Personalized Strategies for Managing in Elderly Type 2 Diabetes Patients
July 28, 2024 · 17 citations · Open access
Open original record →2023 Diabetic Kidney Disease Fact Sheet in Korea
March 19, 2024 · 31 citations · Open access
Open original record →Differing Efficacy of Dapagliflozin Versus Empagliflozin on the Risk of Incident Atrial Fibrillation in Patients With Type 2 Diabetes: A Real‐World Observation Using a Nationwide, Population‐Based Cohort
January 23, 2024 · 24 citations · Open access
Open original record →Comparative cardiovascular outcomes in type 2 diabetes patients taking dapagliflozin versus empagliflozin: a nationwide population-based cohort study
July 26, 2023 · 34 citations · Open access
Open original record →Real-World Prescription Patterns and Barriers Related to the Use of Sodium-Glucose Cotransporter 2 Inhibitors among Korean Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease
June 3, 2022 · 30 citations · Open access
Open original record →Sodium–Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score–Matched Cohort Study
July 22, 2021 · 22 citations · Open access
Open original record →Renal outcomes and all‐cause death associated with sodium‐glucose co‐transporter‐2 inhibitors versus other glucose‐lowering drugs ( CVD‐REAL 3 Korea )
October 29, 2020 · 24 citations · Open access
Open original record →